Medical Condition

endothelial dysfunction

Total Trials

9

Recruiting Now

9

Trial Phases

Phase 2, Phase 1, Phase 1, Phase 2

ClinicalMetric tracks all active clinical trials for endothelial dysfunction sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — endothelial dysfunction Clinical Trials

How many clinical trials are currently recruiting for endothelial dysfunction?

ClinicalMetric currently tracks 9 actively recruiting clinical trials for endothelial dysfunction, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 9. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for endothelial dysfunction?

endothelial dysfunction research spans Phase 1 (2 trials), Phase 2 (3 trials), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a endothelial dysfunction clinical trial?

Eligibility criteria for endothelial dysfunction trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 1

Phase 2

Phase 4

Top Sponsors

Assistance Publique - Hôpitaux de Paris 1 trial

Pär Johansson 1 trial

University of Wisconsin, Madison 1 trial

Kalie Tommerdahl 1 trial

University of Calgary 1 trial

Recruiting Clinical Trials

NCT04558450

Recruiting

Covid-19 Effects on Arterial Stiffness and Vascular Aging (CARTESIAN)

Assistance Publique - Hôpitaux...

View Trial →

NCT06319274 Phase 2

Recruiting

Infusion of Prostacyclin vs Placebo for 72-hours in Mechanically Ventilated Patients With Acute Respiratory Failure

ACEs, SIRT1, and Premature Vascular Aging in Humans

University of Wisconsin, Madis...

View Trial →

NCT05065372 Phase 1

Recruiting

MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes

NCT03255408 Phase 1, Phase 2

Recruiting

Cerebral Blood Flow and Ventilatory Responses During Sleep in Normoxia and Intermittent Hypoxia

University of Calgary

View Trial →

NCT06308952 Phase 4

Recruiting

Atorvastatin Pretreatment in Cerebrovascular Events (APICES) After Flow Diverter Implantation

The Effect of Cytisine Treatment for Smoking Cessation on Cardiovascular Function in Adult Smokers

Ischemic Conditioning to Promote Microvascular Resiliency in Frail Individuals

Medical College of Wisconsin

View Trial →

NCT05939934

Recruiting

Impact of the Mandibular Advancement Device on Sleep Apnea During CPAP Withdrawal

University Hospital, Angers

View Trial →

Related Conditions

arterial stiffness (2) covid19 (1) diastolic dysfunction (1) acute respiratory failure (1) pulmonary infection (1) adverse childhood experiences (1) type 1 diabetes (1) diabetic kidney disease (1) cardiovascular diseases (1) insulin sensitivity (1) obstructive sleep apnea of adult (1) hypoxia brain (1)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology